High Plasminogen Activator Inhibitor and Tissue Plasminogen Activator Levels in Plasma Precede a First Acute Myocardial Infarction in Both Men and Women: Evidence for the Fibrinolytic System as an Independent Primary Risk Factor

Coronary Plaque Disruption

Falk, E., Shah, P. K., & Fuster, V. (1995) · Circulation · doi:10.1161/01.cir.92.3.657 · Cited by 3,536 · see citing works

Myocardial infarction and coronary deaths in the World Health Organization MONICA Project. Registration procedures, event rates, and case-fatality rates in 38 populations from 21 countries in four continents.

Tunstall-Pedoe, H., Kuulasmaa, K., Amouyel, P., Arveiler, D., Rajakangas, A.-M., & Pająk, A. (1994) · Circulation · doi:10.1161/01.cir.90.1.583 · Cited by 2,260 · see citing works

An updated coronary risk profile. A statement for health professionals.

Anderson, K. M., Wilson, P. W., Odell, P. M., & Kannel, W. B. (1991) · Circulation · doi:10.1161/01.cir.83.1.356 · Cited by 1,834 · see citing works

Hemostatic Factors and the Risk of Myocardial Infarction or Sudden Death in Patients with Angina Pectoris

Thompson, S. G., Kienast, J., Pyke, S., Haverkate, F., & van de Loo, J. C. W. (1995) · New England Journal of Medicine · doi:10.1056/nejm199503093321003 · Cited by 1,819 · see citing works

PLASMINOGEN ACTIVATOR INHIBITOR IN PLASMA: RISK FACTOR FOR RECURRENT MYOCARDIAL INFARCTION

Hamsten, A., Walldius, G., Szamosi, A., Blombäck, M., de Faire, U., Dahlén, G. H., Landou, C., & Wiman, B. (1987) · The Lancet · doi:10.1016/s0140-6736(87)93050-9 · Cited by 1,474 · see citing works

Fibrinolytic activity, clotting factors, and long-term incidence of ischaemic heart disease in the Northwick Park Heart Study

MEADE, T. (1993) · The Lancet · doi:10.1016/0140-6736(93)92062-x · Cited by 711 · see citing works

Endogenous tissue-type plasminogen activator and risk of myocardial infarction

Ridker, P. M., Vaughan, D. E., Manson, J., Hennekens, C. H., & Stampfer, M. (1993) · The Lancet · doi:10.1016/0140-6736(93)90998-v · Cited by 580 · see citing works

Fibrinolytic Factors and the Risk of Myocardial Infarction or Sudden Death in Patients With Angina Pectoris

Juhan-Vague, I., Pyke, S., Alessi, M., Jespersen, J., Haverkate, F., & Thompson, S. G. (1996) · Circulation · doi:10.1161/01.cir.94.9.2057 · Cited by 551 · see citing works

von Willebrand factor in plasma: a novel risk factor for recurrent myocardial infarction and death.

Jansson, J., Nilsson, T., & Johnson, O. (1991) · Heart · doi:10.1136/hrt.66.5.351 · Cited by 356 · see citing works

Clearance of Tissue Plasminogen Activator (TPA) and TPA/Plasminogen Activator Inhibitor Type 1 (PAI-1) Complex: Relationship to Elevated TPA Antigen in Patients With High PAI-1 Activity Levels

Chandler, W. L., Alessi, M. C., Aillaud, M. F., Henderson, P., Vague, P., & Juhan-Vague, I. (1997) · Circulation · doi:10.1161/01.cir.96.3.761 · Cited by 245 · see citing works

Predictive value of tissue plasminogen activator mass concentration on long-term mortality in patients with coronary artery disease. A 7-year follow-up.

Jansson, J.-H., Olofsson, B. O., & Nilsson, T. (1993) · Circulation · doi:10.1161/01.cir.88.5.2030 · Cited by 241 · see citing works

Age dependence of tissue plasminogen activator concentrations in plasma, as studied by an improved enzyme-linked immunosorbent assay.

Rånby, M., Bergsdorf, N., Nilsson, T., Mellbring, G., Winblad, B. G., & Bucht, G. (1986) · Clinical Chemistry · doi:10.1093/clinchem/32.12.2160 · Cited by 192 · see citing works

The PLAT Study: hemostatic function in relation to atherothrombotic ischemic events in vascular disease patients. Principal results. PLAT Study Group. Progetto Lombardo Atero-Trombosi (PLAT) Study Group.

Cortellaro, M., Boschetti, C., Cofrancesco, E., Zanussi, C., Catalano, M., de Gaetano, G., Gabrielli, L., Lombardi, B., Specchia, G., & Tavazzi, L. (1992) · Arteriosclerosis and Thrombosis A Journal of Vascular Biology · doi:10.1161/01.atv.12.9.1063 · Cited by 187 · see citing works

How well can we predict coronary heart disease? Findings in the United Kingdom Heart Disease Prevention Project.

Heller, R. F., Chinn, S., Pedoe, H. D., & Rose, G. (1984) · BMJ · doi:10.1136/bmj.288.6428.1409 · Cited by 179 · see citing works

Tissue plasminogen activator and other risk factors as predictors of cardiovascular events in patients with severe angina pectoris

Jansson, J., Nilsson, T., & OLOFSSON, B. O. (1991) · European Heart Journal · doi:10.1093/oxfordjournals.eurheartj.a059862 · Cited by 174 · see citing works

The Epidemiology of DHEAS and Cardiovascular Disease

Barrett-Connor, E. L., & Goodman‐Gruen, D. (1995) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1995.tb17386.x-i1 · Cited by 167 · see citing works

Enzyme immunoassay for factor VIII-related antigen.

Čejka, J. (1982) · Clinical Chemistry · doi:10.1093/clinchem/28.6.1356 · Cited by 161 · see citing works

Plasminogen Activator System in Human Coronary Atherosclerosis

Raghunath, P. N., Tomaszewski, J. E., Brady, S. T., Caron, R. J., Okada, S., & Barnathan, E. S. (1995) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.15.9.1432 · Cited by 126 · see citing works

The hemostatic system and coronary heart disease

Hamsten, A. (1993) · Thrombosis Research · doi:10.1016/0049-3848(93)90221-9 · Cited by 104 · see citing works

Maximum Likelihood Fitting of General Risk Models to Stratified Data

Storer, B. E., Wacholder, S., & Breslow, N. E. (1983) · Journal of the Royal Statistical Society Series C (Applied Statistics) · doi:10.2307/2347296 · Cited by 90 · see citing works

Perceived health modifies the effect of biomedical risk factors in the prediction of acute myocardial infarction. An incident case–control study from northern Sweden

Weinehall, L., Johnson, Jansson, Boman, Huhtasaari, Hallmans, Dahlén, & Wall (1998) · Journal of Internal Medicine · doi:10.1046/j.1365-2796.1998.00201.x · Cited by 67 · see citing works

Cellular Interactions, Growth Factors, and Smooth Muscle Proliferation in Atherogenesisa

Ross, R., Masuda, J., & Raines, E. W. (1990) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1990.tb42282.x · Cited by 66 · see citing works

Cardiovascular risk factors in the Northern Sweden MONICA Study.

Huhtasaari, F., Asplund, K., & Wester, P. (2009) · Acta Medica Scandinavica · doi:10.1111/j.0954-6820.1988.tb16746.x · Cited by 61 · see citing works

Atheromatous plaque macrophages produce plasminogen activator inhibitor type-1 and stimulate its production by endothelial cells and vascular smooth muscle cells.

Tipping, P. G., Davenport, P., Gallicchio, M., Filonzi, E. L., Apostolopoulos, J. J., & Wojta, J. (1993) · PubMed Central · Cited by 55 · see citing works

Impaired Fibrinolysis and the Risk for Coronary Heart Disease

Lijnen, H. R., & Collen, D. (1996) · Circulation · doi:10.1161/01.cir.94.9.2052 · Cited by 46 · see citing works

Why are Diabetes, Stomach Cancer and Circulatory Diseases More Common in Northern Sweden?

Nyström, L., Rosén, M., & Wall, S. (1986) · Scandinavian Journal of Primary Health Care · doi:10.3109/02813438609013963 · Cited by 35 · see citing works

Monocytes enhance the bidirectional release of type I plasminogen activator inhibitor by endothelial cells

Hakkert, B. C., Rentenaar, J., & van MOURIK, J. A. (1990) · Blood · doi:10.1182/blood.v76.11.2272.2272 · Cited by 31 · see citing works

Hemostatic Factors and the Risk of Myocardial Infarction

Otto, C., & Richter, W. O. (1995) · New England Journal of Medicine · doi:10.1056/nejm199508103330616 · Cited by 25 · see citing works

Electron Microscopic Exploration of Human Endothelium in Step‐Serial Sections of Early and Advanced Atherosclerotic Lesions

Constantinides, P., & Harkey, M. (1990) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1990.tb42283.x · Cited by 23 · see citing works

Endothelial Haemostatic Factors May Be Associated with Mortality in Patients on Long-term Anticoagulant Treatment

Brännström, M., Jansson, J., Boman, K., & Nilsson, T. (1995) · Thrombosis and Haemostasis · doi:10.1055/s-0038-1649784 · Cited by 15 · see citing works

The clinical implications of endothelial dysfunction

Widlansky, M. E., Gokce, N., Keaney, J. F., & Vita, J. A. (2003) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(03)00994-x · Cited by 1,749 · see citing works

Multiple Biomarkers for the Prediction of First Major Cardiovascular Events and Death

Wang, T. J., Gona, P. N., Larson, M. G., Tofler, G. H., Levy, D. A., Newton‐Cheh, C., Jacques, P. F., Rifai, N., Selhub, J., Robins, S. J., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa055373 · Cited by 1,342 · see citing works

Elevated Levels of Acute-Phase Proteins and Plasminogen Activator Inhibitor-1 Predict the Development of Type 2 Diabetes

Festa, A., D’Agostino, R., Tracy, R. P., & Haffner, S. M. (2002) · Diabetes · doi:10.2337/diabetes.51.4.1131 · Cited by 1,057 · see citing works

Systemic Effects of Smoking

Yanbaeva, D. G., Dentener, M. A., Creutzberg, E. C., Wesseling, G., & Wouters, E. F. �. (2007) · CHEST Journal · doi:10.1378/chest.06-2179 · Cited by 1,022 · see citing works

Inflammation in Atherosclerosis: From Vascular Biology to Biomarker Discovery and Risk Prediction

Packard, R. R. S., & Libby, P. (2008) · Clinical Chemistry · doi:10.1373/clinchem.2007.097360 · Cited by 925 · see citing works

The endocrine function of adipose tissue: an update

Ronti, T., Lupattelli, G., & Mannarino, E. (2006) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2006.02474.x · Cited by 906 · see citing works

Endothelial dysfunction: cardiovascular risk factors, therapy, and outcome.

Hadi, H. A. R., Carr, C. S., & Suwaidi, J. M. S. A. (2005) · PubMed Central · Cited by 807 · see citing works

Plasminogen-Activator Inhibitor Type 1 and Coronary Artery Disease

Kohler, H. P., & Grant, P. J. (2000) · New England Journal of Medicine · doi:10.1056/nejm200006153422406 · Cited by 805 · see citing works

Minireview: Adiposity, Inflammation, and Atherogenesis

Lyon, C. J., Law, R. E., & Hsueh, W. A. (2003) · Endocrinology · doi:10.1210/en.2003-0285 · Cited by 761 · see citing works

The effect of urban air pollution on inflammation, oxidative stress, coagulation, and autonomic dysfunction in young adults

Chuang, K.-J., Chan, C.-C., Su, T.-C., Lee, C.-T., & Tang, C.-S. (2007) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200611-1627oc · Cited by 685 · see citing works

Accelerated atherosclerosis: An extraarticular feature of rheumatoid arthritis?

Doornum, S. V., McColl, G., & Wicks, I. P. (2002) · Arthritis & Rheumatism · doi:10.1002/art.10089 · Cited by 605 · see citing works

PAI‐1 and atherothrombosis

Vaughan, D. E. (2005) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2005.01420.x · Cited by 508 · see citing works

Role of hemostatic gene polymorphisms in venous and arterial thrombotic disease

Lane, D. A., & Grant, P. J. (2000) · Blood · doi:10.1182/blood.v95.5.1517.005k48_1517_1532 · Cited by 492 · see citing works

Obesity-related non-communicable diseases: South Asians vs White Caucasians

Misra, A., & Khurana, L. (2011) · International Journal of Obesity · doi:10.1038/ijo.2010.135 · Cited by 491 · see citing works

Hepatic insulin resistance, metabolic syndrome and cardiovascular disease

Meshkani, R., & Adeli, K. (2009) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2009.05.018 · Cited by 458 · see citing works

Established and Emerging Plasma Biomarkers in the Prediction of First Atherothrombotic Events

Ridker, P. M., Brown, N. J., Vaughan, D. E., Harrison, D. G., & Mehta, J. L. (2004) · Circulation · doi:10.1161/01.cir.0000133444.17867.56 · Cited by 418 · see citing works

Effects of Psychological Stress and Psychiatric Disorders on Blood Coagulation and Fibrinolysis: A Biobehavioral Pathway to Coronary Artery Disease?

von Känel, R., Mills, P. J., Fainman, C., & Dimsdale, J. E. (2001) · Psychosomatic Medicine · doi:10.1097/00006842-200107000-00003 · Cited by 422 · see citing works

Von Willebrand Factor in Cardiovascular Disease

Spiel, A. O., Gilbert, J. C., & Jilma, B. (2008) · Circulation · doi:10.1161/circulationaha.107.722827 · Cited by 403 · see citing works

PAI-1 and the Metabolic Syndrome: Links, Causes, and Consequences

Alessi, M.-C., & Juhan-Vague, I. (2006) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000242905.41404.68 · Cited by 390 · see citing works

Plasminogen activator inhibitor-1, inflammation, obesity, insulin resistance and vascular risk

Juhan-Vague, I., Alessi, M.-C., Mavri, A., & Morange, P. E. (2003) · Journal of Thrombosis and Haemostasis · doi:10.1046/j.1538-7836.2003.00279.x · Cited by 371 · see citing works

Obesity, haemostasis and the fibrinolytic system

Mertens, I. L., & Gaal, L. F. V. (2002) · Obesity Reviews · doi:10.1046/j.1467-789x.2002.00056.x · Cited by 368 · see citing works

A systematic review: Burden and severity of subclinical cardiovascular disease among those with nonalcoholic fatty liver; Should we care?

Oni, E., Agatston, A. S., Blaha, M. J., Fialkow, J. A., Cury, R. C., Sposito, A. C., Erbel, R., Blankstein, R., Feldman, T., Al-Mallah, M. H., et al. (2013) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2013.07.052 · Cited by 352 · see citing works

Hyperglycemia: a prothrombotic factor?

Lemkes, B. A., Hermanides, J., DeVries, J. H., Holleman, F., Meijers, J. C. M., & Hoekstra, J. B. L. (2010) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2010.03910.x · Cited by 348 · see citing works

von Willebrand factor, endothelial dysfunction, and cardiovascular disease

Vischer, U. M. (2006) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2006.01949.x · Cited by 343 · see citing works

von Willebrand Factor, C-Reactive Protein, and 5-Year Mortality in Diabetic and Nondiabetic Subjects

Jager, A., van Hinsbergh, V. W. M., Kostense, P. J., EMEIS, J. J., Yudkin, J. S., Nijpels, G., Dekker, J. M., Heine, R. J., Bouter, L. M., & Stehouwer, C. D. A. (1999) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.19.12.3071 · Cited by 288 · see citing works

von Willebrand factor and coronary heart disease. Prospective study and meta-analysis

Whincup, P. H. (2002) · European Heart Journal · doi:10.1053/euhj.2001.3237 · Cited by 271 · see citing works

Alcohol Consumption and Hemostatic Factors

Mukamal, K. J., Jadhav, P. P., D’Agostino, R. B., Massaro, J. M., Mittleman, M. A., Lipinska, I., Sutherland, P. A., Matheney, T. H., Levy, D. A., Wilson, P. W. F., et al. (2001) · Circulation · doi:10.1161/hc3701.096067 · Cited by 248 · see citing works

Prospective Study of Fibrinolytic Factors and Incident Coronary Heart Disease

Folsom, A. R., Aleksic, N., Park, E., Salomaa, V. V., Juneja, H. S., & Wu, K. K. (2001) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.21.4.611 · Cited by 234 · see citing works

The metabolic syndrome and cardiovascular disease

Bonora, E. (2006) · Annals of Medicine · doi:10.1080/07853890500401234 · Cited by 231 · see citing works

Cardiovascular disease and diabetes in the Northern Sweden Health and Disease Study Cohort- evaluation of risk factors and their interactions

Hallmans, G., Ågren, Å., Johansson, G., Johansson, A. S., Stegmayr, B., Jansson, J., Lindahl, B., Rolandsson, O., Söderberg, S., Nilsson, M., et al. (2003) · Scandinavian Journal of Public Health · doi:10.1080/14034950310001432 · Cited by 223 · see citing works

Periadventitial Adipose Tissue Plays a Critical Role in Vascular Remodeling

Takaoka, M., Nagata, D., Kihara, S., Shimomura, I., Kimura, Y., Tabata, Y., Saito, Y., Nagai, R., & Sata, M. (2009) · Circulation Research · doi:10.1161/circresaha.109.199653 · Cited by 217 · see citing works

Effects of Lifestyle on Hemostasis, Fibrinolysis, and Platelet Reactivity: A Systematic Review

Lee, K. W., & Lip, G. Y. H. (2003) · Archives of Internal Medicine · doi:10.1001/archinte.163.19.2368 · Cited by 217 · see citing works

Endothelial Cell Markers and the Risk of Coronary Heart Disease

Morange, P., Simon, C., Alessi, M., Luc, G., Arveiler, D., Ferrières, J., Amouyel, P., Evans, A., Ducimetière, P., & Juhan-Vague, I. (2004) · Circulation · doi:10.1161/01.cir.0000120705.55512.ec · Cited by 215 · see citing works

Effects of an ad libitum low-glycemic load diet on cardiovascular disease risk factors in obese young adults

Ebbeling, C. B., Leidig, M. M., Sinclair, K. B., Seger-Shippee, L. G., Feldman, H. A., & Ludwig, D. S. (2005) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/81.5.976 · Cited by 213 · see citing works

Shadows of complexity: what biological networks reveal about epistasis and pleiotropy

Tyler, A. L., Asselbergs, F. W., Williams, S. M., & Moore, J. H. (2009) · BioEssays · doi:10.1002/bies.200800022 · Cited by 185 · see citing works

Adipose tissue and metabolic syndrome: too much, too little or neither

Grundy, S. M. (2015) · European Journal of Clinical Investigation · doi:10.1111/eci.12519 · Cited by 187 · see citing works

Prothrombotic factors in histologically proven nonalcoholic fatty liver disease and nonalcoholic steatohepatitis

Verrijken, A., Francque, S., Mertens, I. L., Prawitt, J., Caron, S., Hubens, G., Marck, E. V., Staels, B., Michielsen, P. P., & Gaal, L. V. (2013) · Hepatology · doi:10.1002/hep.26510 · Cited by 180 · see citing works

Tissue plasminogen activator antigen and coronary heart disease Prospective study and meta-analysis

Lowe, G. D. O. (2004) · European Heart Journal · doi:10.1016/j.ehj.2003.11.004 · Cited by 179 · see citing works

Obesity, Peroxisome Proliferator-Activated Receptor, and Atherosclerosis in Type 2 Diabetes

Blaschke, F., Takata, Y., Caglayan, E., Law, R. E., & Hsueh, W. A. (2006) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000191663.12164.77 · Cited by 176 · see citing works

Among inflammation and coagulation markers, PAI-1 is a true component of the metabolic syndrome

Mertens, I. L., Verrijken, A., Michiels, J. J., van der Planken, M., Ruige, J. B., & Gaal, L. F. V. (2006) · International Journal of Obesity · doi:10.1038/sj.ijo.0803189 · Cited by 176 · see citing works

Comorbidity, Hospitalization, and Mortality in COPD: Results from a Longitudinal Study

Terzano, C., Conti, V., Stefano, F. D., Petroianni, A., Ceccarelli, D., Graziani, E., Mariotta, S., Rícci, A., Vitarelli, A., Puglisi, G., et al. (2010) · Lung · doi:10.1007/s00408-009-9222-y · Cited by 176 · see citing works

Apoptosis signal-regulating kinase 1 mediates cellular senescence induced by high glucose in endothelial cells

Yokoi, T., Fukuo, K., Yasuda, O., Hotta, M., Miyazaki, J., Takemura, Y., Kawamoto, H., Ichijo, H., & Ogihara, T. (2006) · Diabetes · doi:10.2337/db05-1607 · Cited by 169 · see citing works

Age-Dependent Spontaneous Coronary Arterial Thrombosis in Transgenic Mice That Express a Stable Form of Human Plasminogen Activator Inhibitor-1

Eren, M., Painter, C., Atkinson, J. B., Declerck, P. J., & Vaughan, D. E. (2002) · Circulation · doi:10.1161/01.cir.0000023186.60090.fb · Cited by 170 · see citing works

Nontraditional Risk Factors for Cardiovascular Disease in Diabetes

Fonseca, V. A., Desouza, C. V., Asnani, S., & Jialal, I. (2004) · Endocrine Reviews · doi:10.1210/er.2002-0034 · Cited by 165 · see citing works

Local adipose tissue depots as cardiovascular risk factors

Thalmann, S., & MEIER, C. (2007) · Cardiovascular Research · doi:10.1016/j.cardiores.2007.03.008 · Cited by 162 · see citing works

Virchow’s Triad Revisited: Blood Constituents

Chung, I. K.-K., & Lip, G. Y. H. (2003) · Pathophysiology of Haemostasis and Thrombosis · doi:10.1159/000083844 · Cited by 161 · see citing works

Predictors of the first cardiovascular event in patients with systemic lupus erythematosus - a prospective cohort study

Gustafsson, J. T., Gunnarsson, I., Börjesson, O., Pettersson, S., Möller, S., Fei, G., Elvin, K., Simard, J. F., Hansson, L., Lundberg, I. E., et al. (2009) · Arthritis Research & Therapy · doi:10.1186/ar2878 · Cited by 157 · see citing works

Extracellular Proteases in Atherosclerosis and Restenosis

García‐Touchard, A., Henry, T. D., Sangiorgi, G., Spagnoli, L. G., Mauriello, A., Conover, C. A., & Schwartz, R. S. (2005) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000164311.48592.da · Cited by 157 · see citing works

Epidemiology of breast cancer, a paradigm of the “common soil” hypothesis

Iacoviello, L., Bonaccio, M., de Gaetano, G., & Donati, M. B. (2020) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2020.02.010 · Cited by 154 · see citing works

Atherosclerotic Plaque Rupture

Lutgens, E., van Suylen, R. J., Faber, B. C. G., Gijbels, M. J., Eurlings, P. M. H., Bijnens, A. P., Cleutjens, K. B. J. M., Heeneman, S., & Daemen, M. J. A. P. (2003) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000097783.01596.e2 · Cited by 154 · see citing works

Estimated intake of milk fat is negatively associated with cardiovascular risk factors and does not increase the risk of a first acute myocardial infarction. A prospective case–control study

Warensjö, E., Jansson, J., Berglund, L., Boman, K., Åhrén, B., Weinehall, L., Lindahl, B., Hallmans, G., & Vessby, B. O. (2004) · British Journal Of Nutrition · doi:10.1079/bjn20041080 · Cited by 153 · see citing works

Plasminogen activator inhibitor (PAI)-1 in vascular inflammation and thrombosis

Aso, Y. (2007) · Frontiers in bioscience · doi:10.2741/2285 · Cited by 147 · see citing works

Microalbuminuria, decreased fibrinolysis, and inflammation as early signs of atherosclerosis in long-term survivors of disseminated testicular cancer

Nuver, J., Smit, A. J., Sleijfer, D. T., van Gessel, A. I., van Roon, A. M., van der Meer, J., van den Berg, M. P., Burgerhof, J. G. M., Hoekstra, H. J., Sluiter, W. J., et al. (2004) · European Journal of Cancer · doi:10.1016/j.ejca.2003.12.012 · Cited by 147 · see citing works

Methods for Evaluating Endothelial Function in Humans

Barac, A., Campia, U., & Panza, J. A. (2007) · Hypertension · doi:10.1161/01.hyp.0000259601.38807.a6 · Cited by 142 · see citing works

LDL receptor-related protein-1 regulates NFκB and microRNA-155 in macrophages to control the inflammatory response

Mantuano, E., Brifault, C., Lam, M. S., Azmoon, P., Gilder, A. S., & Gonias, S. L. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1515480113 · Cited by 141 · see citing works

Von Willebrand factor and ADAMTS13 in arterial thrombosis: a systematic review and meta-analysis

Sonneveld, M., de Maat, M. P. M., & Leebeek, F. W. G. (2014) · Blood Reviews · doi:10.1016/j.blre.2014.04.003 · Cited by 139 · see citing works

Components of the Fibrinolytic System Are Differently Altered in Moderate and Severe Hypothyroidism

Chadarévian, R., Bruckert, É., Leenhardt, L., Giral, P., Ankri, A., & Turpin, G. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.2.7221 · Cited by 138 · see citing works

The Biochemistry, Physiology and Pathological roles of PAI-1 and the requirements for PAI-1 inhibition in vivo

Craen, B. V. D., Declerck, P. J., & Gils, A. (2012) · Thrombosis Research · doi:10.1016/j.thromres.2012.06.023 · Cited by 138 · see citing works

Increased Incidence of Coronary Atherosclerosis in Type 2 Diabetes Mellitus: Mechanisms and Management

Hurst, R. T., & Lee, R. W. (2003) · Annals of Internal Medicine · doi:10.7326/0003-4819-139-10-200311180-00010 · Cited by 137 · see citing works

In Search of Fewer Independent Risk Factors

Brotman, D. J. (2005) · Archives of Internal Medicine · doi:10.1001/archinte.165.2.138 · Cited by 138 · see citing works

The Vasculature in Prediabetes

Wasserman, D. H., Wang, T. J., & Brown, N. J. (2018) · Circulation Research · doi:10.1161/circresaha.118.311912 · Cited by 137 · see citing works

Myocardial infarction with normal coronary arteries: a conundrum with multiple aetiologies and variable prognosis: an update

Kardasz, I., & Caterina, R. D. (2007) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2007.01788.x · Cited by 134 · see citing works

Causal Effect of Plasminogen Activator Inhibitor Type 1 on Coronary Heart Disease

Song, C., Burgess, S., Eicher, J. D., O’Donnell, C. J., Johnson, A. D., Huang, J., Sabater‐Lleal, M., Asselbergs, F. W., Trégouët, D., Shin, S., et al. (2017) · Journal of the American Heart Association · doi:10.1161/jaha.116.004918 · Cited by 133 · see citing works

State of the art paper Central obesity, type 2 diabetes and insulin: exploring a pathway full of thorns

Papaetis, G. S., Papakyriakou, P., & Panagiotou, T. N. (2015) · Archives of Medical Science · doi:10.5114/aoms.2015.52350 · Cited by 135 · see citing works

Effect of plasminogen activator inhibitor–1 in diabetes mellitus and cardiovascular disease

Lyon, C. J., & Hsueh, W. A. (2003) · The American Journal of Medicine · doi:10.1016/j.amjmed.2003.08.014 · Cited by 131 · see citing works

Nonalcoholic fatty liver disease as a multi-systemic disease

Fotbolcu, H., & Zorlu, E. (2016) · World Journal of Gastroenterology · doi:10.3748/wjg.v22.i16.4079 · Cited by 129 · see citing works

Peroxisome Proliferator-Activated Receptor γ: Implications for Cardiovascular Disease

Hsueh, W. A., & Bruemmer, D. (2004) · Hypertension · doi:10.1161/01.hyp.0000113626.76571.5b · Cited by 130 · see citing works

Circulating levels and hepatic expression of molecular mediators of atherosclerosis in nonalcoholic fatty liver disease

Sookoian, S. C., Castaño, G. O., Burgueño, A. L., Rosselli, M. S., Gianotti, T. F., Mallardi, P., Martino, J. S., & Pirola, C. J. (2009) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2009.10.011 · Cited by 128 · see citing works

Impact of weight reduction on production of platelet-derived microparticles and fibrinolytic parameters in obesity

Murakami, T., Horigome, H., Tanaka, K., Nakata, Y., Ohkawara, K., Katayama, Y., & Matsui, A. (2006) · Thrombosis Research · doi:10.1016/j.thromres.2005.12.013 · Cited by 127 · see citing works

Plasminogen activator inhibitor-type 1: its plasma determinants and relation with cardiovascular risk

Hoekstra, T., Schouten, E. G., Kluft, C., & Geleijnse, J. M. (2004) · Thrombosis and Haemostasis · doi:10.1160/th03-08-0546 · Cited by 126 · see citing works

ADAMTS13 and von Willebrand factor and the risk of myocardial infarction in men

Chion, C. K. N. K., Doggen, C. J. M., Crawley, J. T. B., Lane, D. A., & Rosendaal, F. R. (2006) · Blood · doi:10.1182/blood-2006-07-038166 · Cited by 126 · see citing works

Hemostatic Risk Factors for Atherothrombotic Disease: An Epidemiologic View

Folsom, A. R. (2001) · Thrombosis and Haemostasis · doi:10.1055/s-0037-1616234 · Cited by 126 · see citing works

Ultrasmall superparamagnetic iron oxide nanoparticles acutely promote thrombosis and cardiac oxidative stress and DNA damage in mice

Nemmar, A., Beegam, S., Yuvaraju, P., Yasin, J., Tariq, S., Attoub, S., & Ali, B. H. (2015) · Particle and Fibre Toxicology · doi:10.1186/s12989-016-0132-x · Cited by 125 · see citing works

A Serpin With a Finger in Many PAIs: PAI-1's Central Function in Thromboinflammation and Cardiovascular Disease

Morrow, G. B., Whyte, C. S., & Mutch, N. J. (2021) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2021.653655 · Cited by 121 · see citing works

Cardiovascular disease in diabetes mellitus type 2: a potential role for novel cardiovascular risk factors

Hayden, J. M., & Reaven, P. D. (2000) · Current Opinion in Lipidology · doi:10.1097/00041433-200010000-00010 · Cited by 121 · see citing works

EPIC-Heart: The cardiovascular component of a prospective study of nutritional, lifestyle and biological factors in 520,000 middle-aged participants from 10 European countries

Danesh, J., Saracci, R., Berglund, G. L., Feskens, E. J. M., Overvad, K., Panico, S., Thompson, S. G., Fournier, A., Clavel‐Chapelon, F., Canonico, M., et al. (2007) · European Journal of Epidemiology · doi:10.1007/s10654-006-9096-8 · Cited by 121 · see citing works

Long‐term effects of weight loss with a very low carbohydrate and low fat diet on vascular function in overweight and obese patients

Wycherley, T. P., Brinkworth, G. D., Keogh, J. B., Noakes, M., Buckley, J. D., & Clifton, P. M. (2009) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2009.02174.x · Cited by 120 · see citing works

The Metabolic Syndrome in Women

Schneider, J. G., TOMPKINS, C. M., Blumenthal, R. S., & Mora, S. (2006) · Cardiology in Review · doi:10.1097/01.crd.0000233757.15181.67 · Cited by 120 · see citing works

Plasminogen activator inhibitor and the risk of cardiovascular disease: The Framingham Heart Study

Tofler, G. H., Massaro, J. M., O’Donnell, C. J., Wilson, P. W. F., Vasan, R. S., Sutherland, P. A., Meigs, J. B., Levy, D. A., & D’Agostino, R. B. (2016) · Thrombosis Research · doi:10.1016/j.thromres.2016.02.002 · Cited by 117 · see citing works

Association between plasminogen activator inhibitor-1 and cardiovascular events: a systematic review and meta-analysis

Jung, R. G., Motazedian, P., Ramirez, F. D., Simard, T., Santo, P. D., Visintini, S. M., Faraz, M. A., Labinaz, A., Jung, Y., & Hibbert, B. M. (2018) · Thrombosis Journal · doi:10.1186/s12959-018-0166-4 · Cited by 116 · see citing works

Assessment of Hemostatic Risk Factors in Predicting Arterial Thrombotic Events

Feinbloom, D. B., & Bauer, K. A. (2005) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000181762.31694.da · Cited by 112 · see citing works

Rho-Kinase Mediates Hyperglycemia-Induced Plasminogen Activator Inhibitor-1 Expression in Vascular Endothelial Cells

Rikitake, Y., & Liao, J. K. (2005) · Circulation · doi:10.1161/circulationaha.105.534024 · Cited by 113 · see citing works

Testosterone and Atherosclerosis in Aging Men

Jones, R. D., Nettleship, J. E., Kapoor, D., Jones, H. T., & Channer, K. S. (2005) · American Journal of Cardiovascular Drugs · doi:10.2165/00129784-200505030-00001 · Cited by 111 · see citing works

Past, Present, and Future Perspectives of Plasminogen Activator Inhibitor 1 (PAI-1)

Morrow, G. B., & Mutch, N. J. (2022) · Seminars in Thrombosis and Hemostasis · doi:10.1055/s-0042-1758791 · Cited by 110 · see citing works

Coronary atherogenic risk factors in women.

Stangl, V., Baumann, G., & Stangl, K. (2002) · European Heart Journal · doi:10.1053/euhj.2002.3329 · Cited by 124 · see citing works

Functional Stability of Plasminogen Activator Inhibitor-1

Yıldız, S. Y., Bektaşoğlu, P. K., Öner, E. T., & Ağırbaşlı, M. A. (2014) · The Scientific World JOURNAL · doi:10.1155/2014/858293 · Cited by 106 · see citing works

Adipose Tissue‐Derived Plasminogen Activator Inhibitor‐1 Function and Regulation

Kaji, H. (2016) · Comprehensive physiology · doi:10.1002/cphy.c160004 · Cited by 106 · see citing works

Biological Profiles in Subjects With Recurrent Acute Coronary Events Compared With Subjects With Long-Standing Stable Angina

Bogaty, P. M., Poirier, P., Simard, S., Boyer, L., Solymoss, S., & Dagenais, G. R. (2001) · Circulation · doi:10.1161/01.cir.103.25.3062 · Cited by 103 · see citing works

Plasminogen Activator Inhibitor Type-1 in Cardiovascular Disease

Huber, K., Christ, G., Wojta, J., & Gulba, D. C. (2001) · Thrombosis Research · doi:10.1016/s0049-3848(01)00293-6 · Cited by 103 · see citing works

Systemic and vascular markers of inflammation in relation to metabolic syndrome and insulin resistance in adults with elevated atherosclerosis risk

Kressel, G., Trunz, B., Bub, A., Hülsmann, O., Wolters, M., Lichtinghagen, R., Stichtenoth, D. O., & Hahn, A. (2008) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2008.04.012 · Cited by 99 · see citing works

Role of functional plasminogen-activator-inhibitor-1 4G/5G promoter polymorphism in susceptibility, severity, and outcome of meningococcal disease in Caucasian children*

Haralambous, E., Hibberd, M. L., Hermans, P. W. M., Ninis, N., Nadel, S., & Levin, M. (2003) · Critical Care Medicine · doi:10.1097/01.ccm.0000100122.57249.5d · Cited by 101 · see citing works

Particulate Matter-Induced Lung Inflammation Increases Systemic Levels of PAI-1 and Activates Coagulation Through Distinct Mechanisms

Budinger, G. R. S., McKell, J. L., Urich, D., Foiles, N., Weiss, I. M., Chiarella, S. E., Gonzalez, A., Soberanes, S., Ghio, A. J., Niğdelioğlu, R., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0018525 · Cited by 100 · see citing works

Insulin resistance syndrome: interaction with coagulation and fibrinolysis

Köhler, H.-P. (2002) · Swiss Medical Weekly · doi:10.4414/smw.2002.09856 · Cited by 94 · see citing works

Aldosterone and Not Plasminogen Activator Inhibitor-1 Is a Critical Mediator of Early Angiotensin II/ N G -Nitro- l -Arginine Methyl Ester-Induced Myocardial Injury

Oestreicher, E. M., Martinez-Vasquez, D., Stone, J. R., Jonasson, L., Roubsanthisuk, W., Mukasa, K., & Adler, G. K. (2003) · Circulation · doi:10.1161/01.cir.0000097000.51723.6f · Cited by 93 · see citing works

Progress in Understanding Metabolic Syndrome and Knowledge of Its Complex Pathophysiology

Jha, B. K., Sherpa, M. L., Imran, M., Mohammed, Y., Jha, L. A., Paudel, K. R., & Jha, S. K. (2023) · Diabetology · doi:10.3390/diabetology4020015 · Cited by 103 · see citing works

Genome-wide association and linkage analyses of hemostatic factors and hematological phenotypes in the Framingham Heart Study

Yang, Q., Kathiresan, S., Lin, J., Tofler, G. H., & O’Donnell, C. J. (2007) · BMC Medical Genetics · doi:10.1186/1471-2350-8-s1-s12 · Cited by 91 · see citing works

Unraveling the Pivotal Role of Bradykinin in ACE Inhibitor Activity

Taddei, S., & Bortolotto, L. A. (2016) · American Journal of Cardiovascular Drugs · doi:10.1007/s40256-016-0173-4 · Cited by 90 · see citing works

Effect of weight loss on inflammatory and endothelial markers and FMD using two low-fat diets

Clifton, P. M., Keogh, J. B., Foster, P., & Noakes, M. (2005) · International Journal of Obesity · doi:10.1038/sj.ijo.0803039 · Cited by 89 · see citing works

Coagulability in Obstructive Sleep Apnea

Liak, C., & Fitzpatrick, M. (2011) · Canadian Respiratory Journal · doi:10.1155/2011/924629 · Cited by 89 · see citing works

Bradykinin stimulates the release of tissue plasminogen activator in human coronary circulation: effects of angiotensin-converting enzyme inhibitors

Minai, K., Matsumoto, T., Horie, H., Ohira, N., Takashima, H., Yokohama, H., & Kinoshita, M. (2001) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(01)01202-5 · Cited by 86 · see citing works

Tissue plasminogen activator antigen is strongly associated with myocardial infarction in young women

Mannucci, P. M., Bernardinelli, L., Foco, L., Galli, M., Ribichini, F. L., Marco Tubaro, U., & Peyvandi, F. (2005) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2005.01116.x · Cited by 44 · see citing works

Increased tissue factor pathway inhibitor in patients with acute myocardial infarction

Kamikura, Y., Wada, H., Yamada, A., Shimura, M., Hiyoyama, K., Shiku, H., Tanigawa, M., Nishikawa, H., Yamada, N., Isaka, N., et al. (1997) · American Journal of Hematology · doi:10.1002/(sici)1096-8652(199707)55:4 · Cited by 48 · see citing works

Plasma and Platelet Plasminogen Activator Inhibitor-1 in Patients With Acute Myocardial Infarction

Soeki, T., Tamura, Y., Fukuda, N., & Ito, S. (2000) · Japanese Circulation Journal-english Edition · doi:10.1253/jcj.64.547 · Cited by 13 · see citing works

Serum levels of thrombotic markers in patients with acute myocardial infarction.

Islam, S., Yakout, S. M., Al‐Daghri, N. M., Alhomida, A. S., & Khan, H. A. (2014) · Europe PMC (PubMed Central) · Cited by 8 · see citing works

Evaluation of tissue plasminogen activator and plasminogen activator inhibitor-I levels in acute myocardial infarction.

Yamada, S., Yamada, R., ISHII, A., Ashikawa, K., Kawamitsu, H., & Fujita, K. (1996) · PubMed · Cited by 8 · see citing works